- ICH GCP
- EUs kliniske prøveregister
Siste forsøk
EudraCT Number: 2004-000805-23 | Sponsor Protocol Number: LEV102341 | Start Date: 2004-09-21 | |||||||||||
Sponsor Name: GLAXO SMITHKLINE | |||||||||||||
Full Title: A national, multicentric, randomised, controlled trial. Applications of a critical pathway using LEVOFLOXACIN for the management of patients with abnormal PSA | |||||||||||||
Medical condition: prostatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001883-39 | Sponsor Protocol Number: P02561 | Start Date: 2004-09-21 | |||||||||||
Sponsor Name: Schering Plough Reserach Institute | |||||||||||||
Full Title: Study to Evaluate the Effect of the Coadministration of SCH 497079 (a Histamine 3 [H3] Receptor Antagonist) Plus Desloratadine on Nasal Congestion in Subjects With Seasonal Allergic Rhinitis Who Ha... | |||||||||||||
Medical condition: Seasonal Allergic Rhinitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000185-12 | Sponsor Protocol Number: CELC200A2401 / 2939107 | Start Date: 2004-09-21 | |||||||||||
Sponsor Name: Orion Corporation, ORION PHARMA | |||||||||||||
Full Title: A long term, double-blind, randomized, parallel-group, carbidopa/levodopa controlled, multi-center study to evaluate the effect of Stalevo® in patients with Parkinson’s disease requiring initiation... | |||||||||||||
Medical condition: Parkinson's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) SE (Completed) AT (Completed) GB (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-002249-11 | Sponsor Protocol Number: BLQ-01-003-04 | Start Date: 2004-09-20 | ||||||
Sponsor Name: BAUSCH&LOMB - IOM S.P.A. | ||||||||
Full Title: Double blind, randomized, multicenter, placebo-controlled, parallel-group design clinical trial of the efficacy and tolerability of cloriclomene hydrochloride capsules 100 mg TID in diabetic patien... | ||||||||
Medical condition: Mild to moderate non-proliferative diabetic retinopathy | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: IT (Prematurely Ended) | ||||||||
Trial results: View results |
EudraCT Number: 2004-001600-12 | Sponsor Protocol Number: F/2004/2. | Start Date: 2004-09-20 | ||||||
Sponsor Name: OMNINVEST Kft. | ||||||||
Full Title: Fluval AB Vaccine Serologic Clinical Trial | ||||||||
Medical condition: Immunization of healthy people against influenza virus infections. | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: HU (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-000838-36 | Sponsor Protocol Number: PX104.1.7-201 | Start Date: 2004-09-20 | ||||||
Sponsor Name: Pharmexa A/S | ||||||||
Full Title: A Phase II trial evaluating the immunological and clinical efficay and safety of HER-2 Protein Autovac(TM) monotherapy in patients with metastatic breast cancer | ||||||||
Medical condition: Female patients with histologically proven metastatic or locally advanced breast cancer who have HER-2 overexpression in the primary tumour and/or a metastatic lesion. | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||
Trial protocol: HU (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000083-27 | Sponsor Protocol Number: GT-08 | Start Date: 2004-09-19 | ||||||
Sponsor Name: ALK-Abelló A/S | ||||||||
Full Title: A randomised, parallel-group, double-blind, placebo-controlled Phase III trial assessing the efficacy and safety of ALK Grass Tablet Phleum pratense in subjects with seasonal grass pollen induced r... | ||||||||
Medical condition: Rhinoconjunctivitis | ||||||||
|
||||||||
Population Age: Adults | Gender: Male, Female | |||||||
Trial protocol: SE (Completed) IT (Completed) ES (Completed) AT (Completed) GB (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-000091-14 | Sponsor Protocol Number: FFR102123 | Start Date: 2004-09-17 | ||||||
Sponsor Name: GlaxoSmithKline, S.A | ||||||||
Full Title: A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multicentre, Long-Term Study to Evaluate the Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg ... | ||||||||
Medical condition: Perennial allergic rhinitis | ||||||||
|
||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: ES (Completed) SE (Completed) LV (Completed) LT (Completed) IT (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-002137-39 | Sponsor Protocol Number: V1 25/07/04 | Start Date: 2004-09-17 | ||||||
Sponsor Name: | ||||||||
Full Title: A randomised controlled trial of the combined use of paracetamol and ibuprofen to treat febrile children | ||||||||
Medical condition: Fevers in childhood not asscoaited with severe disease in the immunocompenetent or fever in the immunocompromised host. | ||||||||
|
||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001347-29 | Sponsor Protocol Number: | Start Date: 2004-09-17 | |||||||||||
Sponsor Name: Odense University Hospital | |||||||||||||
Full Title: Treatment of patients with locally advanced rectal cancer. TEGAFOX (UFT/leukovorin og Oxaliplatin) before, during and after curatively intended radiotherapy. A Danish phase I/II trial | |||||||||||||
Medical condition: Locally advanced non-resectable rectal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |